Lih-Ching Hsu Selected Research

hemiasterlin

1/2016	Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth.
8/2012	Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lih-Ching Hsu Research Topics

Disease

15	Prostatic Neoplasms (Prostate Cancer) 06/2020 - 06/2012
13	Neoplasms (Cancer) 01/2022 - 02/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 12/2007
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Inflammation (Inflammations) 12/2020 - 12/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2020 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
2	Leukemia 01/2019 - 12/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020
1	Lung Neoplasms (Lung Cancer) 08/2020
1	Malaria 01/2020
1	Triple Negative Breast Neoplasms 01/2019
1	Cardiotoxicity 01/2018
1	Erectile Dysfunction 01/2018
1	Ischemia 06/2017
1	Tics (Tic) 06/2017
1	Glioblastoma (Glioblastoma Multiforme) 09/2015
1	Type 2 Diabetes Mellitus (MODY) 08/2013
1	Carcinogenesis 02/2005
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2004
1	Hypersensitivity (Allergy) 07/2004

Drug/Important Bio-Agent (IBA)

10	Hormones (Hormone)IBA 01/2019 - 06/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2013
3	Pharmaceutical PreparationsIBA 01/2022 - 09/2015
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 06/2020 - 01/2013
3	MK 2206IBA 01/2019 - 01/2015
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2015
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2004
2	Biological ProductsIBA 12/2020 - 01/2019
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 01/2018
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2019
2	artenimol (dihydroartemisinin)IBA 01/2020 - 01/2019
2	CholesterolIBA 01/2018 - 12/2007
2	hemiasterlinIBA 01/2016 - 08/2012
2	TubulinIBA 11/2015 - 02/2005
2	reevesioside FIBA 09/2015 - 12/2013
2	Adenosine Triphosphatases (ATPase)IBA 09/2015 - 12/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 06/2012
2	Phosphotransferases (Kinase)IBA 01/2014 - 11/2002
2	CaspasesIBA 01/2014 - 01/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	ChalconesIBA 12/2020
1	Cyclin B1IBA 08/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 08/2020
1	PhosphoproteinsIBA 08/2020
1	Proteins (Proteins, Gene)FDA Link 06/2020
1	brevipolide HIBA 06/2020
1	CyclinsIBA 06/2020
1	Sildenafil Citrate (Viagra)FDA Link 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	artemisinin (artemisinine)IBA 01/2020
1	WZB117IBA 01/2019
1	4-toluenesulfonamideIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	LipidsIBA 01/2018
1	Topoisomerase II InhibitorsIBA 01/2018
1	Peptides (Polypeptides)IBA 11/2017
1	DipeptidesIBA 11/2017
1	Cell ExtractsIBA 06/2017
1	Oxygen (Dioxygen)IBA 06/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2016
1	TriazolesIBA 11/2016
1	NeurotoxinsIBA 12/2015
1	nitroxolineIBA 11/2015
1	zerumboneIBA 11/2015
1	SesquiterpenesIBA 11/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2015
1	Cardiac GlycosidesIBA 09/2015
1	Ouabain (G Strophanthin)IBA 09/2015
1	Phentolamine (Z-Max)FDA LinkGeneric 09/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2015
1	Cytotoxins (Cytolysins)IBA 01/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015
1	Caspase 2IBA 01/2014
1	reevesioside AIBA 01/2014
1	Histamine Receptors (Histamine Receptor)IBA 01/2014
1	Histones (Histone)IBA 01/2014
1	CardenolidesIBA 01/2014
1	Terfenadine (Seldane)IBA 01/2014
1	GlycosidesIBA 01/2014
1	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2013
1	Blood Glucose (Blood Sugar)IBA 08/2013
1	SurvivinIBA 01/2013
1	Inhibitor of Apoptosis ProteinsIBA 01/2013
1	ardisianone AIBA 01/2013
1	quinone (benzoquinone)IBA 01/2013
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2012
1	CamptothecinIBA 07/2012
1	rottlerinIBA 07/2012
1	Progesterone FDA LinkGeneric 12/2007
1	N 30IBA 02/2005
1	ParaffinIBA 02/2005
1	Indicators and Reagents (Reagents)IBA 02/2005

Therapy/Procedure

5	Castration 06/2020 - 09/2015
5	Therapeutics 01/2020 - 07/2012
4	Drug Therapy (Chemotherapy) 06/2020 - 01/2013